User menu

BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival

Bibliographic reference Haguet, Hélène ; Douxfils, Jonathan ; Mullier, François ; Chatelain, Christian ; Graux, Carlos ; et. al. BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival.Belgian Haematological Society (La Hulpe, Belgique, du 29/01/2016 au 30/01/2016).
Permanent URL http://hdl.handle.net/2078.1/179448